跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RIVA-IRBESARTAN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
RIVA-IRBESARTAN
Authorized
STANDARD
RIVA-IRBESARTAN
laboratoire riva inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
667832e71db26986
Company
laboratoire riva inc.
Type
Standard
Approval Details
Approval Id
667832e71db26986
Drug Approval Canada Name
RIVA-IRBESARTAN
Product Name
RIVA-IRBESARTAN
Status
Marketed
Status Date
2023-06-08
Original Market Date
2023-06-08
Din
02524732
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:32.08
Atc Original
C09CA04 IRBESARTAN
Atc Name
c 09 ca 04
Aig Number
0131700001
Company Name
laboratoire riva inc.
Company Address
660 Boul. Industriel, Blainville, Quebec, Canada, J7C 3V4
Active Ingredients
IRBESARTAN
75 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
667832e71db26986
Type
Standard
Back to Health Canada Approvals